Fabrizio CANTİNİ, Laura NİCCOLİ, Carlotta NANNİNİ, Emanuele CASSARÀ, Olga KALOUDİ

Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator

Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet’s disease after switching from infliximab originator

European Journal of Rheumatology

2017-Cilt: 4 - Sayı: 4

58-60

202

Benzer Makaleler

Low frequency of HLA-B27 in ankylosing spondylitis and its relationship with clinical findings in patients from Turkey

European Journal of Rheumatology

Ayşe CEFLE, Ayten YAZICI, Hakan SAVLI, Barış YILMAZER, Sevde Nur FIRAT, Fulya COŞAN

Cutaneous calcinosis in a patient with limited scleroderma: CREST Syndrome

European Journal of Rheumatology

Nurşen DÜZGÜN

Case series: Monoarticular rheumatoid arthritis

European Journal of Rheumatology

Jeffrey SARAZİN, Rajaie N NAMAS, Elena SCHİOPU

An unusual flare of anti-synthetase syndrome during concurrent trastuzumab therapy given for recurrent breast cancer

European Journal of Rheumatology

Timothy D REYNOLDS, Vivek MOHAN, Matthew ROY, Nathan MANGHAT, Huzaifa ADAMALİ, Harsha GUNAWARDENA

Top 100 cited articles in the field of rheumatology

European Journal of Rheumatology

Yu Heng KWAN, Chi Jun CHUA, Jing Xun LESTER KİAN, Warren FONG

ABO blood groups and rheumatic diseases

European Journal of Rheumatology

Taşkın ŞENTÜRK, Songül ÇİLDAĞ, Yasemin KARA

The real-world use of different anti-tumor necrosis factor agents in a Northern European population of patients with Behçet’s disease

European Journal of Rheumatology

Wan Lin NG, Alexander Duncan FRASER, Joseph DEVLİN, Maria Usman KHAN, Fahd ADEEB, Austin G STACK2

Behçet’s disease in the United States: A single center descriptive and comparative study

European Journal of Rheumatology

Nathan C. KİLİAN, Amr H. SAWALHA